These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10087321)

  • 41. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections.
    Satra M; Dalekos GN; Kollia P; Vamvakopoulos N; Tsezou A
    J Viral Hepat; 2005 Sep; 12(5):488-93. PubMed ID: 16108763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
    Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
    J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
    Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
    Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
    Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
    Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
    J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical localization of hTERT protein in human tissues.
    Yan P; Benhattar J; Seelentag W; Stehle JC; Bosman FT
    Histochem Cell Biol; 2004 May; 121(5):391-7. PubMed ID: 15138842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
    Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
    J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.
    Soria JC; Moon C; Wang L; Hittelman WN; Jang SJ; Sun SY; Lee JJ; Liu D; Kurie JM; Morice RC; Lee JS; Hong WK; Mao L
    J Natl Cancer Inst; 2001 Aug; 93(16):1257-63. PubMed ID: 11504771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.
    Saleh S; Lam AK; Ho YH
    Pathology; 2008 Jan; 40(1):25-30. PubMed ID: 18038311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3].
    Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
    Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL
    Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.